| LncRNA Information | ||||||
|---|---|---|---|---|---|---|
| ID | EL0490 | Name | FAR2P1 | Aliases | HEL-182 | |
| Species | Homo sapiens | Chromosome | 2 | Start site | 129990456 | |
| End site | 130051131 | Chain | minus | Exon NO. | 12 | |
| Assembly | Ensembl Release 89 | Class | processed transcript | NCBI accession | NR_026758 | |
| Ensembl | ENSG00000180178 | Sequence | ||||
| Disease | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
| lung adenocarcinoma | microarray, qPCR etc. | lung adenocarcinoma tissue | down-regulated | expression | RP11-133F8.2 expression of EGFR exon 19 deletions in lung adenocarcinoma was significantly higher than wild-type EGFR tissues, while LOC440905 expression of EGFR exon 19 deletions in lung adenocarcinoma was significantly lower than wild-type EGFR tissues. RP11-325I22.2 and LOC440905 might play an important role in the mechanism of EGFR exon 19 deletion in lung adenocarcinoma. | 25085781 | Lnc2Cancer | ||
| non-small cell lung cancer | microarray, qPCR etc. | NSCLC tissue | up-regulated | expression | we initially identified a number of significant candidate lncRNAs (including GUCY1B2, RP11-385J1.2, AC018865.8, RP11-909N17.3, GNAS-AS1, TUBA4B, Z82214.3, XLOC_000371, AC013264.2 and RP1-317E23.3) and verified the expression of these lncRNAs by RT-qPCR with GAPDH as the reference gene, by calculating the 2-CT values. | 25394782 | Lnc2Cancer | ||